Objective To evaluate the efficacy and safety of an oral selective tyrosine kinase 2 (TYK2) inhibitor, deucravacitinib, in patients with active psoriatic arthritis (PsA). Methods In this double-blind, ...

(UroToday.com) In the Rapid Abstract Session on the first day of the American Society for Clinical Oncology (ASCO) Genitourinary Cancer Symposium 2022, Dr. Gao presented results of a phase 1/2 study ...

followed by a phase 2 part of SHR-1501 plus BCG in multiple cohorts: Cohort A: BCG-naïve NMIBC Cohort B: BCG-unresponsive NMIBC (CIS +/- papillary disease) Cohort C: BCG-unresponsive papillary disease ...

Supergiant Games has announced that they are putting the final touches on Hades 2 for its official launch, after more than a ...

While there isn't a 1.0 launch date for Hades 2 just yet, Supergiant Games notes that development is approaching the home stretch.

1 MAIA has announced the trial design for an expansion of its THIO-101 pivotal Phase 2 trial in NSCLC to assess overall response rates (ORR) in advanced NSCLC patients receiving third line (3L ...

The Karnataka State Cabinet has approved the establishment of Quantum Research Park Phase 2 at the Indian Institute of Science, Bengaluru (IISc), as announced by Karnataka’s information technology (IT ...

Pioneering small-molecule program, NT-0796, targets chronic inflammation and its fundamental role in the complex cycle of weight regulation Oral, brain-penetrant NLRP3 inflammasome inhibitor being ...

IVMED-85 is a non-atropine eye drop that strengthens collagen crosslinks to prevent pediatric myopia progression. Initial studies in guinea pigs demonstrated reduced myopia progression and no observed ...

updated the Phase 1 study results of IBI343, a novel anti-CLDN18.2 ADC, for the treatment of advanced pancreatic cancer at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting. With ...

drug showed a three-month survival increase in a phase 2 study. The Texas- and Ireland-based biotech evaluated the therapy in a trial of 286 patients with metastatic pancreatic ductal ...